The burden of hospitalization related to diabetes mellitus: a population-based study.

BACKGROUND AND AIMS To estimate the impact of diabetes and its complications, overall and in different age classes, on the likelihood of hospital admission for specific causes. METHODS AND RESULTS We carried out a record-linkage analysis of administrative registers including data on 8,940,420 citizens in 21 Local Health Authorities in Italy. Individuals with pharmacologically treated diabetes (≥2 prescriptions of antidiabetic agents during the year 2008) were paired in a 1:1 proportion with those who did not receive such drugs (controls) based on propensity-score matching. Odds Ratios (ORs) of hospitalization for macro and microvascular conditions in individuals with diabetes as compared to controls were estimated. The system identified 498,825 individuals with diabetes pharmacologically treated (prevalence of 5.6%). Prevalence of diabetes in people aged <14 years, 14-39 years, 40-65 years, and ≥65 years was 0.1%, 0.6%, 6.4%, and 18.2%, respectively. Overall, 23.9% of subjects with diabetes and 11.5% of controls had had at least a hospital admission during 12 months for the causes considered. Diabetes increased the likelihood of hospitalization by two to six times for the different causes examined. In absolute terms, diabetes was responsible for an excess of over 12,000 hospital admissions per 100,000 individuals/year. CONCLUSION Despite the availability of effective treatments to prevent or delay major complications, diabetes still places an enormous burden on both patients and the health care system. Given the continuous rise in diabetes prevalence both in middle-aged and elderly individuals, we can expect an additional, hardly sustainable increase in the demand for health care in the near future.

[1]  N. Marchionni,et al.  Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  Dorte Vistisen,et al.  Global healthcare expenditure on diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[3]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[4]  G. Bruno,et al.  Socio-economic differences in the prevalence of diabetes in Italy: the population-based Turin study. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[5]  M. Woodward,et al.  Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. , 2009, Archives of internal medicine.

[6]  M. Engelgau,et al.  The Evolving Diabetes Burden in the United States , 2004, Annals of Internal Medicine.

[7]  G. Bruno,et al.  Changes over time in the prevalence and quality of care of type 2 diabetes in Italy: the Casale Monferrato surveys, 1988 and 2000. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[8]  J. Ma,et al.  The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis. , 2009, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[9]  A. Nicolucci,et al.  Baseline Quality-of-Care Data From a Quality-Improvement Program Implemented by a Network of Diabetes Outpatient Clinics , 2008, Diabetes Care.

[10]  Elaine L. Zanutto,et al.  Estimating causal effects of public health education campaigns using propensity score methodology , 2005 .

[11]  L. Tavazzi,et al.  Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation. , 2006, European heart journal.

[12]  G. Tognoni,et al.  The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure , 2007, European journal of heart failure.

[13]  A. Green,et al.  Rising prevalence of diabetes: evidence from a Danish pharmacoepidemiological database. , 2003, The Lancet.

[14]  D. Louis,et al.  Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy , 2005, Journal of health services research & policy.

[15]  Gianni Tognoni,et al.  Quality of diabetes care predicts the development of cardiovascular events: results of the QuED study. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[16]  J. Ayanian Using administrative data to assess health care outcomes. , 1999, European heart journal.

[17]  P. Donnan,et al.  Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a retrospective cohort study of resource use. , 2000, Diabetes care.

[18]  Charles Maynard,et al.  The burden of diabetes-associated cardiovascular hospitalizations in Veterans Administration (VA) and non-VA medical facilities. , 2004, Diabetes care.

[19]  P. Zimmet Globalization, coca‐colonization and the chronic disease epidemic: can the Doomsday scenario be averted? , 2000, Journal of internal medicine.

[20]  J. Avorn,et al.  A review of uses of health care utilization databases for epidemiologic research on therapeutics. , 2005, Journal of clinical epidemiology.

[21]  Peter C Austin,et al.  A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study , 2007, Statistics in medicine.

[22]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[23]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[24]  V. Basevi Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.